Product image of Pamorelin La (Triptorelin) supplied by GNH India

Pamorelin La

Active Ingredient:
Triptorelin
Origin:
EU

Pamorelin La (Triptorelin)

Triptorelin, the active ingredient in Pamorelin La, is a gonadotropin-releasing hormone (GnRH) agonist presented as a sterile powder for solution for injection use. It is employed in the management of hormone‑dependent conditions such as prostate cancer, endometriosis and assisted reproductive protocols in adults.
GNH India supplies Pamorelin La as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Manufacturer / TM Owner

Ipsen Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pamorelin La (triptorelin) acts on the gonadotropin‑releasing hormone pathway and is indicated for several hormone‑dependent conditions.

  • Prostate cancer: provides hormonal suppression to slow disease progression.
  • Endometriosis: reduces pelvic pain and lesion growth by lowering estrogen levels.
  • Assisted reproduction (IVF): triggers controlled ovarian stimulation for oocyte retrieval.
  • Precocious puberty: delays further sexual development by suppressing gonadotropin release.
  • Uterine fibroids: alleviates symptoms through estrogen suppression.

How It Works

  • Triptorelin is a synthetic analogue of GnRH that binds with high affinity to pituitary GnRH receptors. Continuous stimulation leads to receptor desensitisation and down‑regulation, markedly decreasing the secretion of luteinising hormone (LH) and follicle‑stimulating hormone (FSH). The resulting drop in circulating sex steroids (testosterone and estradiol) produces the therapeutic hormonal suppression required for its indicated uses.

Side Effects

Adverse reactions to triptorelin vary with the indication and duration of therapy.

Common Side Effects

  • Hot flashes: transient warmth and sweating episodes.
  • Injection site reactions: redness, swelling or mild pain.
  • Headache: mild to moderate intensity.
  • Fatigue: general tiredness or lack of energy.
  • Nausea: mild gastrointestinal upset.
  • Mood changes: irritability or mild depression.

Serious or Rare Side Effects

  • Cardiovascular events: hypertension, myocardial infarction or stroke.
  • Bone loss: decreased bone mineral density leading to osteoporosis.
  • Severe allergic reaction: anaphylaxis, angioedema or urticaria.
  • Hormonal crisis: acute adrenal insufficiency or adrenal crisis.
  • Pituitary apoplexy: sudden hemorrhage into the pituitary gland.
  • Liver dysfunction: marked elevation of transaminases.

Precautions & Warnings

When using triptorelin, clinicians should consider several safety aspects.

  • Cardiovascular assessment: evaluate history of hypertension, heart disease or stroke risk.
  • Bone health monitoring: baseline densitometry and periodic follow‑up for osteoporosis risk.
  • Hormonal status: assess baseline testosterone/estradiol levels and adjust therapy accordingly.
  • Pregnancy and lactation: contraindicated in pregnant or nursing women; effective contraception required.
  • Drug interactions: review concomitant medications that affect hormone metabolism.
  • Store at below 25°C: keep in the original packaging, protect from moisture and light.

Avoid Interactions

Triptorecin may interact with other medicines that influence hormonal pathways or cardiovascular function.

Major Interactions (Avoid)

  • Anticoagulants: increased bleeding risk when combined with GnRH‑induced endothelial changes.
  • CYP3A4 inhibitors: may alter hormone metabolism and increase systemic exposure.

Moderate Interactions (Monitor Closely)

  • Steroids: additive effects on bone density loss.
  • Thyroid hormone replacement: may require dose adjustment due to altered hormone dynamics.
  • Antihypertensive agents: blood pressure response may be modified.
  • Antidepressants (SSRIs): potential for heightened mood‑related side effects.
  • Diuretics: electrolyte balance may shift with hormonal changes.

Frequently Asked Questions

Pamorelin La contains triptorelin, a GnRH agonist approved for hormone‑dependent conditions such as advanced prostate cancer, endometriosis, uterine fibroids, precocious puberty and for triggering ovarian stimulation in assisted reproductive technology cycles.

Triptorelin mimics natural GnRH and binds to pituitary GnRH receptors. Continuous exposure desensitises these receptors, sharply reducing luteinising hormone and follicle‑stimulating hormone release, which in turn lowers circulating testosterone and estradiol levels, providing the hormonal suppression needed for its therapeutic effects.

The specific dose and administration schedule of Pamorelin La are determined by the prescribing clinician based on the indication, patient characteristics and treatment goals. Healthcare professionals should follow the product’s prescribing information and adjust dosing as required.

Pamorelin La is contraindicated in pregnancy and breastfeeding because it suppresses sex‑steroid production, which can harm fetal development and affect milk production. Effective contraception is required for women of child‑bearing potential during treatment.

To order Pamorelin La, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Pamorelin La (triptorelin) is chemically similar to other GnRH agonists such as leuprolide and goserelin, offering comparable efficacy in hormone suppression. Differences may lie in dosing frequency, formulation (e.g., depot versus short‑acting), and manufacturer‑specific excipients, which can influence convenience and patient preference.

Store Pamorelin La below 25 °C in its original container, protecting it from moisture and direct light. Do not freeze the product, and keep it out of reach of children.

Pamorelin La is supplied as a sterile powder that must be reconstituted with the provided diluent and administered by subcutaneous or intramuscular injection according to the prescribing clinician’s instructions.

Serious risks include cardiovascular events such as hypertension or stroke, severe bone loss leading to osteoporosis, allergic reactions like anaphylaxis, and rare hormonal crises. Patients should be monitored regularly for these potential complications.

Pamorelin La is contraindicated in individuals with known hypersensitivity to triptorelin or any formulation components, pregnant or nursing women, and patients with uncontrolled cardiovascular disease or severe osteoporosis without appropriate management.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Triptorelin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT